TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

TransMedics (Nasdaq: TMDX) will release fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 after market close.

Rhea-AI Summary

TransMedics (Nasdaq: TMDX) will release fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026 after market close.

The company will host a management conference call at 4:30 p.m. ET / 1:30 p.m. PT with domestic dial-in (800) 715-9871, international (646) 307-1963 and access code 8036478. A live and archived webcast will be available on the company's Investors website.

Argus Feb 11 session

-4.30% close to close Open Argus

Details

News Market Reaction – TMDX

On Feb 11, the first trading day after this news, TMDX closed 4.30% below the previous close.

Data tracked by StockTitan Argus for the Feb 11 session.

Key Figures

Earnings release date: February 24, 2026 Conference call time ET: 4:30 p.m. ET Conference call time PT: 1:30 p.m. PT +3 more

Earnings release date

February 24, 2026

Q4 and full year 2025 financial results release after market close

Conference call time ET

4:30 p.m. ET

Start time for earnings conference call

Conference call time PT

1:30 p.m. PT

Start time for earnings conference call

Access code

8036478

Investor dial-in access code for the conference call

Domestic dial-in

(800) 715-9871

U.S. investor conference call number

International dial-in

(646) 307-1963

International investor conference call number

Historical Context

5 past events · Latest: Jan 12

5 events

1. Jan 12

   HQ expansion lease

   24h Move

   -1.8%

   Long-term Somerville HQ lease and integrated campus with incentive packages.

2. Dec 30

   Conference participation

   24h Move

   -0.2%

   Participation in the 44th Annual J.P. Morgan Healthcare Conference.

3. Dec 24

   Inducement grants

   24h Move

   -2.2%

   Inducement stock options and RSUs granted to new employees.

4. Dec 09

   Program expansion

   24h Move

   -1.3%

   Strategic collaboration to deploy a fleet and establish Italian OCS hubs.

5. Nov 18

   Conference fireside chat

   24h Move

   +3.2%

   Participation in Piper Sandler 37th Annual Healthcare Conference fireside chat.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

ANDOVER, Mass., Feb. 10, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today announced that it will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 24, 2026. The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

Investors interested in listening to the conference call may do so by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers and providing access code 8036478. A live and archived webcast of the event will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com/. 

About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in Andover, Massachusetts, the company was founded to address the unmet need for more and better organs for transplantation and has developed technologies to preserve organ quality, assess organ viability prior to transplant, and potentially increase the utilization of donor organs for the treatment of end-stage heart, lung, and liver failure.

Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-report-fourth-quarter-and-full-year-2025-financial-results-on-february-24-2026-302684181.html

SOURCE TransMedics Group, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will TransMedics (TMDX) report Q4 and full year 2025 results?

TransMedics will report Q4 and full year 2025 results after market close on February 24, 2026. According to TransMedics, the company will follow the release with a management conference call at 4:30 p.m. ET to discuss results and answer investor questions.

How can investors join the TransMedics (TMDX) earnings call on February 24, 2026?

Investors can join the TransMedics earnings call by dialing (800) 715-9871 domestic or (646) 307-1963 international with access code 8036478. According to TransMedics, a live and archived webcast will also be available on the Investors section of the company website.

What time is the TransMedics (TMDX) conference call for the 2025 results?

The TransMedics conference call is scheduled for 4:30 p.m. ET / 1:30 p.m. PT on February 24, 2026. According to TransMedics, management will present the results on the call and provide a live webcast and archived replay on the investor website.

Where will the TransMedics (TMDX) webcast of the February 24, 2026 call be available?

The live and archived webcast will be available on the Investors section of the TransMedics website at https://investors.transmedics.com/. According to TransMedics, the webcast will host the management presentation and an archived replay after the call concludes.

Will TransMedics (TMDX) provide an archived replay of the Q4 2025 earnings call?

Yes, TransMedics will provide an archived webcast replay of the Q4 2025 earnings call on its investor website. According to TransMedics, the archived webcast will be posted after the live event for investor access and review.